ACMM
KDNY

Arbor Capital Management (Minnesota)’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Arbor Capital Management (Minnesota)’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$1.48M Buy
+26,128
New +$1.59M 0.78% 66

Other funds holding KDNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Arbor Capital Management (Minnesota)'s KDNY Position: Q2 2016 in Review

Arbor Capital Management (Minnesota) opened a new position in Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2016: 26,128 shares worth $1.48M. The stake represents 0.78% of the portfolio and ranks #66 among its holdings.

102 funds tracked by Wall St. Rank hold KDNY as of Q2 2016.

  • Arbor Capital Management (Minnesota) held 26,128 shares of Chinook Therapeutics, Inc. Common Stock worth $1.48M as of Q2 2016.
  • Chinook Therapeutics, Inc. Common Stock was a new Arbor Capital Management (Minnesota) position in Q2 2016.
  • Chinook Therapeutics, Inc. Common Stock made up 0.78% of Arbor Capital Management (Minnesota)'s portfolio in Q2 2016, its #66 holding.
  • 102 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Arbor Capital Management (Minnesota)'s 13F filing for Q2 2016, filed 15 Aug 2016.